ResearcherMie UniversityActive in the last 2 years
Miki Usui
Matched on ORCID iD 0000-0001-7083-0067; OpenAlex author ID A5070348965. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 3
- Prognostic Significance of Portal Vein Tumor Thrombus in Pancreatic Ductal Adenocarcinoma Treated With Chemoradiotherapy. Co-author DOI 10.1002/ags3.70186↗
- Tumor Budding Is an Independent Adverse Prognostic Factor of Pancreatic Ductal Adenocarcinoma Patients Treated by Resection After Preoperative Chemoradiotherap… Co-author DOI 10.1097/mpa.0000000000002440↗
- Prognostic impact of the distance from the anterior surface to tumor cells in pancreatoduodenectomy with neoadjuvant chemoradiotherapy for pancreatic ductal ad… Co-author DOI 10.1371/journal.pone.0307876↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Aoi Hayasaki · 3 shared papers, 2024–2026 · strength 0.74
- Paper Prognostic Significance of Portal Vein Tumor Thrombus in Pancreatic Ductal Adenocarcinoma Treated With Chemoradiotherap… DOI 10.1002/ags3.70186↗
- Paper Prognostic impact of the distance from the anterior surface to tumor cells in pancreatoduodenectomy with neoadjuvant ch… DOI 10.1371/journal.pone.0307876↗
- Paper Tumor Budding Is an Independent Adverse Prognostic Factor of Pancreatic Ductal Adenocarcinoma Patients Treated by Resec… DOI 10.1097/mpa.0000000000002440↗
- Shugo Mizuno · 3 shared papers, 2024–2026 · strength 0.74
- Paper Prognostic Significance of Portal Vein Tumor Thrombus in Pancreatic Ductal Adenocarcinoma Treated With Chemoradiotherap… DOI 10.1002/ags3.70186↗
- Paper Prognostic impact of the distance from the anterior surface to tumor cells in pancreatoduodenectomy with neoadjuvant ch… DOI 10.1371/journal.pone.0307876↗
- Paper Tumor Budding Is an Independent Adverse Prognostic Factor of Pancreatic Ductal Adenocarcinoma Patients Treated by Resec… DOI 10.1097/mpa.0000000000002440↗
- Masashi Kishiwada · 3 shared papers, 2024–2026 · strength 0.74
- Paper Prognostic Significance of Portal Vein Tumor Thrombus in Pancreatic Ductal Adenocarcinoma Treated With Chemoradiotherap… DOI 10.1002/ags3.70186↗
- Paper Prognostic impact of the distance from the anterior surface to tumor cells in pancreatoduodenectomy with neoadjuvant ch… DOI 10.1371/journal.pone.0307876↗
- Paper Tumor Budding Is an Independent Adverse Prognostic Factor of Pancreatic Ductal Adenocarcinoma Patients Treated by Resec… DOI 10.1097/mpa.0000000000002440↗
- Yasuhiro Murata · 2 shared papers, 2025–2026 · strength 0.49
- Paper Prognostic Significance of Portal Vein Tumor Thrombus in Pancreatic Ductal Adenocarcinoma Treated With Chemoradiotherap… DOI 10.1002/ags3.70186↗
- Paper Tumor Budding Is an Independent Adverse Prognostic Factor of Pancreatic Ductal Adenocarcinoma Patients Treated by Resec… DOI 10.1097/mpa.0000000000002440↗
- Naohisa Kuriyama · 2 shared papers, 2025–2026 · strength 0.49
- Paper Prognostic Significance of Portal Vein Tumor Thrombus in Pancreatic Ductal Adenocarcinoma Treated With Chemoradiotherap… DOI 10.1002/ags3.70186↗
- Paper Tumor Budding Is an Independent Adverse Prognostic Factor of Pancreatic Ductal Adenocarcinoma Patients Treated by Resec… DOI 10.1097/mpa.0000000000002440↗
- Masatoshi Watanabe · 2 shared papers, 2024–2025 · strength 0.45
- Paper Prognostic impact of the distance from the anterior surface to tumor cells in pancreatoduodenectomy with neoadjuvant ch… DOI 10.1371/journal.pone.0307876↗
- Paper Tumor Budding Is an Independent Adverse Prognostic Factor of Pancreatic Ductal Adenocarcinoma Patients Treated by Resec… DOI 10.1097/mpa.0000000000002440↗
- Kazuyuki Gyoten · 1 shared paper, 2025 · strength 0.20
- Takahiro Ito · 1 shared paper, 2025 · strength 0.20
- Toru Shinkai · 1 shared paper, 2025 · strength 0.20
- Benson Kaluba · 1 shared paper, 2025 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.